A new pro for non-CF bronchiectasis: associations between the QOL-B and health outcomes

A. Quittner, I. Cruz, K. Marciel, J. Ilowite, M. Gotfried, A. Barker (Coral Gables, Mineola, Phoenix, Portland, United States Of America)

Source: Annual Congress 2009 - Methodological aspects of asthma and COPD epidemiology
Session: Methodological aspects of asthma and COPD epidemiology
Session type: Thematic Poster Session
Number: 1010
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Quittner, I. Cruz, K. Marciel, J. Ilowite, M. Gotfried, A. Barker (Coral Gables, Mineola, Phoenix, Portland, United States Of America). A new pro for non-CF bronchiectasis: associations between the QOL-B and health outcomes. Eur Respir J 2009; 34: Suppl. 53, 1010

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Aetiology of non-CF bronchiectasis in adults and its association to quality of life
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017

Prognostic indicators of adult patients with non-CF bronchiectasis and those with combined COPD and non-CF bronchiectasis
Source: International Congress 2018 – Improving the quality of life of patients with bronchiectasis
Year: 2018


Challenges in the management of non-CF bronchiectasis
Source: International Congress 2016 – Challenges in the management of non-CF bronchiectasis
Year: 2016

Inpatient management of non-CF bronchiectasis: Should patients be managed as in CF?
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010

Hospital admissions are linked to a poor health related quality of life in patients with non cystic fibrosis bronchiectasis
Source: Annual Congress 2007 - Pulmonary infections in the immunocompetent and immunocompromised host
Year: 2007


Predictors of non-cystic fibrosis bronchiectasis in Indigenous adult residents of central Australia: results of a case–control study
Source: ERJ Open Res, 5 (4) 00001-2019; 10.1183/23120541.00001-2019
Year: 2019



External validation of exacerbation and mortality outcomes of health economic decision models for COPD
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016

Exacerbations in non- cystic fibrosis bronchiectasis (NCFB): is there a difference between self-reported events and those defined by the criteria in the literature?
Source: Virtual Congress 2021 – Bronchiectasis and pleural infection
Year: 2021


The paradox of primary care and respiratory health: evidence of benefit for people and populations with asthma and COPD
Source: Annual Congress 2011 - Primary Care Day I: Effective disease- and self-management in primary care
Year: 2011


A meta-analysis of health related quality of life (HRQOL) in non-cystic fibrosis bronchiectasis (NCFB): Association with clinical outcomes
Source: International Congress 2014 – Different interesting issues in respiratory infections: 2
Year: 2014

Non-cystic fibrosis bronchiectasis: etiology and predictors of exacerbations and mortality in patients across the largest health system in central and western Massachusetts
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017


Measuring airway clearance outcomes in bronchiectasis: a review
Source: Eur Respir Rev, 29 (156) 190161; 10.1183/16000617.0161-2019
Year: 2020



Clinical characteristics and health status of spontaneous sputum producers in COPD
Source: International Congress 2015 – Best abstracts in chronic care
Year: 2015

Prevalence of non-cystic fibrosis bronchiectasis in patients with severe asthma: a real-life study
Source: Virtual Congress 2020 – Air pollution and comorbidities
Year: 2020

Measuring disease-specific utilities for chronic obstructive pulmonary disease (COPD) based on health profiles instead of health states
Source: Eur Respir J 2007; 30: Suppl. 51, 630s
Year: 2007

Changing demographics of cystic fibrosis and models of care
Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age
Year: 2020

Global burden of non-cystic fibrosis bronchiectasis: A simple epidemiological analysis
Source: Annual Congress 2012 - Epidemiology of various respiratory diseases
Year: 2012


Frequent outpatient exacerbations of non cystic fibrosis bronchiectasis leads to impaired health related quality of life
Source: Annual Congress 2007 - Different aspects of COPD exacerbations
Year: 2007


Optimising treatment policies and improvement of care: impact on outcome in cystic fibrosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 617s
Year: 2004